Inhibitory effect of A ras homologue member I on pancreatic cancer and its modulation on epithelium growth factor receptor-ras-raf-mitogen-activated protein kinase/extracellular regulated protein kinase/1/2 pathway

Acta Academiae Medicinae Sinicae

Volumn 34, Issue 3, 2012, Pages 197-201

  Lu, Jia ^a   Qian, Jia Ming ^a   Yang, Hong ^a   Li, Jing Nan ^a   Xu, Feng Ji ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Wuxi Hemujia Hospital   (China)

Author keywords

A ras homologue member I; Epithelium growth factor; Epithelium growth factor receptor; Pancreatic cancer; Ras

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; RAF PROTEIN; RAS PROTEIN; DIRAS3 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GROWTH CURVE; HUMAN; HUMAN CELL; PANCREAS CANCER; PLASMID; PROTEIN EXPRESSION; WESTERN BLOTTING; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PANCREATIC NEOPLASMS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84864444318     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2012.03.001     Document Type: Article

References (14)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics 2000 [J]. CA Cancer J Clin, 2000, 50(1):7-33.
2. Vaccaro V, Gelibter A, Bria E, et al. Molecular and genetic bases of pancreatic cancer. [J]. Curr Drug Targets, 2012, 13(6):731-743.
3. Chang ZG, Wei JM, Qin CF, et al. Receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells. [J]. Dig Dis Sci, 2012, 57 (5): 1181-1189.
4. Huang S, Chang IS, Lin W, et al. ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins. [J]. Biosci Rep, 2009, 30(3): 159-168.
5. Caraccialo G, Pozzi D, Caminiti R, et al. Structural characterization of a new lipid/DNA complex showing a selective transfection efficiency in ovarian cancer cells [J]. Eur Phys J E Soft Matter, 2003, 10(4):331-336.
6. Peng H, Xu F, Pershad R, et al. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers [J]. Int J Cancer, 2000, 86(5):690-694. (Pubitemid 30249881)
7. Weber F, Aldred MA, Morrison CD, et al. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis [J]. J Clin Endo Meta, 2005, 90(2):1149-1155.
8. Lu Z, Luo RZ, Lu Y, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells [J]. J Clin Invest, 2008, 118(12):3917-3929.
9. Feng W, Lu Z, Luo RZ, et al. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer [J]. Int J Cancer, 2007, 120(8):1664-1668. (Pubitemid 46399351)
10. Yu Y, Luo R, Lu Z, et al. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers [J]. Methods Enzymol, 2006, 407(1):455-468. (Pubitemid 43815969)
11. Yang H, Lu X, Qian J, et al. Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells [J]. Mol Med Report, 2010, 3(4):581-587.
12. Lu X, Qian J, Yu Y, et al. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest [J]. Oncol Rep, 2009, 22(3): 635-640.